| Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition B Keikhaei, AR Mohseni, R Norouzirad, M Alinejadi, S Ghanbari, F Shiravi, ... European cytokine network 24 (1), 45-52, 2013 | 140 | 2013 |
| Association of dental caries and salivary sIgA with tobacco smoking L Golpasand Hagh, F Zakavi, S Ansarifar, O Ghasemzadeh, G Solgi Australian dental journal 58 (2), 219-223, 2013 | 93 | 2013 |
| HLA class II (DRB, DQA1 and DQB1) allele and haplotype frequencies in the patients with pemphigus vulgaris S Shams, AA Amirzargar, M Yousefi, N Rezaei, G Solgi, F Khosravi, ... Journal of clinical immunology 29 (2), 175-179, 2009 | 86 | 2009 |
| Single-chain variable fragment-based bispecific antibodies: Hitting two targets with one sophisticated arrow R Ahamadi-Fesharaki, A Fateh, F Vaziri, G Solgi, SD Siadat, F Mahboudi, ... Molecular Therapy-Oncolytics 14, 38-56, 2019 | 78 | 2019 |
| Gastroprotective effect of NaHS against mucosal lesions induced by ischemia–reperfusion injury in rat SA Mard, N Neisi, G Solgi, M Hassanpour, M Darbor, M Maleki Digestive diseases and sciences 57 (6), 1496-1503, 2012 | 77 | 2012 |
| Human mesenchymal stem cells respond to native but not oxidized damage associated molecular pattern molecules from necrotic (tumor) material R Lotfi, J Eisenbacher, G Solgi, K Fuchs, T Yildiz, C Nienhaus, ... European Journal of Immunology 41 (7), 2021-2028, 2011 | 77 | 2011 |
| Gastric cancer stem cells effect on Th17/Treg balance; a bench to beside perspective A Rezalotfi, E Ahmadian, H Aazami, G Solgi, M Ebrahimi Frontiers in Oncology 9, 226, 2019 | 69 | 2019 |
| Glutamate receptor, metabotropic 7 (GRM7) gene variations and susceptibility to autism: A case–control study R Noroozi, M Taheri, A Movafagh, R Mirfakhraie, G Solgi, A Sayad, ... Autism Research 9 (11), 1161-1168, 2016 | 69 | 2016 |
| HLA genes as modifiers of response to IFN-β-1a therapy in relapsing-remitting multiple sclerosis M Mazdeh, M Taheri, A Sayad, S Bahram, MD Omrani, A Movafagh, ... Pharmacogenomics 17 (5), 489-498, 2016 | 51 | 2016 |
| Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA G Solgi, D Furst, J Mytilineos, G Pourmand, AA Amirzargar Transplant immunology 26 (2-3), 81-87, 2012 | 49 | 2012 |
| Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients A Esteghamati, O Khalilzadeh, Z Mobarra, M Anvari, M Tahvildari, ... European Journal of Internal Medicine 20 (4), 424-428, 2009 | 48 | 2009 |
| Increased P-35, EBI3 transcripts and other Treg markers in peripheral blood mononuclear cells of breast cancer patients with different clinical stages M Hamidinia, MG Boroujerdnia, A Talaiezadeh, G Solgi, R Roshani, ... Advanced pharmaceutical bulletin 5 (2), 261, 2015 | 41 | 2015 |
| Anti-inflammatory effects of valproic acid in a rat model of renal ischemia/reperfusion injury: alteration in cytokine profile MA Amirzargar, F Yaghubi, M Hosseinipanah, M Jafari, M Pourjafar, ... Inflammation 40 (4), 1310-1318, 2017 | 40 | 2017 |
| Altered expression of microRNAs may predict therapeutic response in rheumatoid arthritis patients M Rezaeepoor, M Pourjafar, A Tahamoli-Roudsari, Z Basiri, M Hajilooi, ... International immunopharmacology 83, 106404, 2020 | 38 | 2020 |
| Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease M Bahabadi, A Mohammadalipour, J Karimi, N Sheikh, G Solgi, ... Immunopharmacology and immunotoxicology 39 (4), 233-242, 2017 | 35 | 2017 |
| Dasatinib prevent hepatic fibrosis induced by carbon tetrachloride (CCl4) via anti-inflammatory and antioxidant mechanism A Mohammadalipour, J Karimi, I Khodadadi, G Solgi, M Hashemnia, ... Immunopharmacology and immunotoxicology 39 (1), 19-27, 2017 | 35 | 2017 |
| Protective effects of combined Losartan and Nilotinib on carbon tetrachloride (CCl4)-induced liver fibrosis in rats J Karimi, A Mohammadalipour, N Sheikh, I Khodadadi, M Hashemnia, ... Drug and chemical toxicology 43 (5), 468-478, 2020 | 34 | 2020 |
| Serum levels of IL-10 and IL-22 cytokines in patients with psoriasis MR Sobhan, M Farshchian, A Hoseinzadeh, HR Ghasemibasir, G Solgi Iranian Journal of Immunology 13 (4), 317-323, 2016 | 34 | 2016 |
| Determination of cytokine levels in multiple sclerosis patients and their relevance with patients' response to Cinnovex M Taheri, S Ghafouri-Fard, G Solgi, A Sayad, M Mazdeh, MD Omrani Cytokine 96, 138-143, 2017 | 33 | 2017 |
| HLA class II allele and haplotype frequencies in Iranian patients with leukemia F Khosravi, A Amirzargar, A Sarafnejad, MH Nicknam, K Alimoghadam, ... Iranian Journal of Allergy, Asthma and Immunology, 137-142, 2007 | 33 | 2007 |
